Business Context and Reporting Period
Company: Harvard Bioscience, Inc. (HBIO)
Filing Type: Form 8-K (Current Report)
Date of Report: May 7, 2024
Reporting Period: The filing announces financial results for the three months ended March 31, 2024.
Key Financial Metrics
The provided text is a cover sheet for a Form 8-K and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, no numerical values for these metrics are available in this document.
Material Changes
The filing text does not provide specific data regarding material changes versus the prior comparable period. It only confirms that results for the quarter ended March 31, 2024, were announced.
Guidance, Outlook, and Management Commentary
Conference Call: Management scheduled a conference call for May 7, 2024, at 8:00 AM ET to discuss the results.
Legal Disclaimer: The information in Item 2.02 and the attached press release is furnished and not deemed "filed" under Section 18 of the Exchange Act, nor is it incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the quarter ended March 31, 2024.
- Verify year-over-year growth rates and margin trends in the full press release.
- Check for any updated forward-looking guidance or outlook provided during the May 7, 2024, conference call.
- Confirm the status of liquidity and debt covenants as detailed in the full financial statements referenced in the press release.